Results 171 to 180 of about 23,764 (260)

Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions. [PDF]

Int J Mol Sci
Zorkina Y, Abramova O, Zubkov E, Gurina O, Ushakova V.   +4 more
europepmc   +1 more source

Printing to Fight Antimicrobial Resistance Through Nano/Microstructured Platforms

The Chemical Record, EarlyView.
Additive manufacturing enables the rational design of structured antimicrobial platforms across multiple length scales, from nanofibrous scaffolds and droplet microreactors to 3D and 4D printed constructs. By engineering confinement, interfacial chemistry, and stimuli‐responsive release, these systems exert localized action through complementary ...
Giorgia Puleo, Silvia Orecchio, Dario Savoca, Claudia Pellerito, Vittorio Ferrara, Vincenzo Piscopo, Sebastiano Alberto Fortuna, Alessandra Giardina, Bruno Pignataro, Paola Costanzo, Floriana Campanile, Giuseppe Arrabito   +11 more
wiley   +1 more source

Author Correction: Polyrotaxane-based supramolecular theranostics. [PDF]

Nat Commun
Yu G, Yang Z, Fu X, Yung BC, Yang J, Mao Z, Shao L, Hua B, Liu Y, Zhang F, Fan Q, Wang S, Jacobson O, Jin A, Gao C, Tang X, Huang F, Chen X.   +17 more
europepmc   +1 more source

Peptide‐directed nanovehicles enabling tumor‐selective ROS amplification and antitumor immunity

VIEW, EarlyView.
Cancer cells are vulnerable to oxidative stress, yet exploit immune tolerance to escape destruction. In contrast, their metabolic profile is markedly altered to support rapid proliferation, accompanied by elevated production of reactive oxygen species (ROS).
Manuela Calin, Galyna Bila, Ileana Manduteanu, Rostyslav Bilyy   +3 more
wiley   +1 more source

Radiopharmaceutical Theranostics in Primary Adrenal Malignancies: A Surgeon's Perspective. [PDF]

Pharmaceuticals (Basel)
Laskou S, Geropoulos G, Radu PA, Pirvu C, Surlin V, Kosmidis C, Psarras K, Pantea S, Strambu V, Sapalidis K.   +9 more
europepmc   +1 more source

The Future of Theranostic Nanoagents [PDF]

Nanomedicine, 2009
openaire   +2 more sources

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

VIEW, EarlyView.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf, Yara Mashal, Afeefa Rao, Nasar Ata, Arun K. Iyer, Farhan Shah   +5 more
wiley   +1 more source

First-in-human <i>ex-vivo</i> validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493). [PDF]

Theranostics
Larcher A, Gelardi F, Antunovic L, Savi A, Olivieri M, Rainone P, Sollini M, Moresco RM, Re C, Cei F, Belladelli F, Musso G, Salerno L, De Cobelli F, Tenace N, Ponzoni M, Cigliola A, Verze P, Bertini R, Briganti A, Montorsi F, Capitanio U, Salonia A, Chiti A.   +23 more
europepmc   +1 more source

Progress in bone tissue engineering biomaterials: Development, challenges, and prospects

VIEW, EarlyView.
Scheme 1 Application of biomaterials in immunomodulation during bone tissue engineering. Abstract Bone defect repair remains a major clinical challenge in orthopedics. Over 2 million cases caused by trauma, tumors, and other factors occur annually, with large‐scale defects posing a particular bottleneck due to limited self‐healing capacity.
Yuanbin Zhang, Junlei Chai, Quanwei Ding, Luping Liu, Kejie Zhang, Jie Lin, Jianhua Zhang, Youju Huang   +7 more
wiley   +1 more source

Ionic thermoelectrics: a soft energy conversion technique. [PDF]

Natl Sci Rev
Liu W, Zhang X, Fang NX.
europepmc   +1 more source